RuxolitinibCmpd1TBK1cancerhodgkin lymphomaB16 melanomaC57BL/6 mice
…ock IFN and PRR signaling through 3-week ex vivo treatment with Ruxolitinib and Cmpd1,6 inhibitors of JAK1/2 (downstream of IFN) and TBK1(d…
1articles mentioning drugs
1drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: TBK1 ×
TBK1
This drug is selected. Its supporting articles are shown below.